Pr Dr Michel Mittelbronn
National Center of Pathology
Head of NCP
+352 621 206 732
Created in January 2017 as part of the Laboratoire national de santé, the neuropathology diagnostic unit is part of the Luxembourg Centre of Neuropathology (LCNP).
Created in January 2017 as part of the Laboratoire national de santé, the neuropathology diagnostic unit is part of the Luxembourg Centre of Neuropathology (LCNP). This unit, under the direction of Professor Michel Mittelbronn, was established in collaboration with the Luxembourg Institute of Health (LIH), and the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg where research units of the LCNP are located.
In connection with the creation of this unit, Professor Mittelbronn was awarded a PEARL chair by the Fondation nationale de la recherche (FNR), which carries with it considerable financial support.
The diagnostic unit provides microscopic analysis of specimen collections of the central nervous system (such as brain tumours), nerves, muscles as well as cytological examination of cerebrospinal fluid. Intestinal biopsies are also examined in relation to autonomic nervous system diseases. The unit is capable of performing neuropathology services required for analysis of nervous system diseases with a focus on brain cancer or Parkinson’s disease/
In addition, the neuropathology service is responsible for medical and scientific autopsies of the central and peripheral nervous system.
The neuropathology unit works closely with the department of forensic medicine of the LNS in connection with forensic autopsies. After macroscopic examination, tissue preparations are assessed using histological, histochemical and immunohistochemical methods.
Genetic and epigenetic tests are conducted via the joint platform of the departments of pathology and genetics.
The neuropathology unit meets all the needs for diagnosis and research within Luxembourg and also accepts cases from abroad.
The creation of the Luxembourg neuropathology centre provides an excellent opportunity to conduct research projects both on brain cancers as well as in the field of neurodegeneration.